Yonsei Med J.  2007 Feb;48(1):24-29. 10.3349/ymj.2007.48.1.24.

Analysis of the Factors Affecting the Success of Weight Reduction Programs

• Kim J
• Park SK
• Lim YJ

• KMID: 1093519
• DOI: http://doi.org/10.3349/ymj.2007.48.1.24

Abstract

Obesity is a risk factor for numerous health problems. Behavior therapy is important for obesity treatment. The aim of the present study was to identify the parameters that are associated with successful weight reduction. A database of 123 subjects who underwent weight reduction programs at the Center for Health Promotion, Samsung Medical Center from June 2001 through November 2004 was retrospectively analyzed. The goal of the program was to reduce the body weight by more than 5% during the follow-up period. The study population was divided into 2 categories (the success group and the failure group) based on the outcome of weight reduction. We analyzed the demographic, laboratory and clinical parameters to determine the predictors of successful weight reduction. The prevalence of success group was 36.6% (45/123). Significant correlations for successful weight reduction were found for the follow up period and the frequency of medical visits. Our results suggest that strong motivation was the most important factor for successful weight reduction.

Keyword

Obesity; weight loss; behavior therapy

Reference

1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004. 291:2847–2850.

2. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993. 119:655–660.

3. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1997. 96:3248–3250.

4. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999. 282:1523–1529.

5. Zachwieja JJ. Exercise as treatment for obesity. Endocrinol Metab Clin North Am. 1996. 25:965–988.

6. Wadden TA, Foster GD, Letizia KA, Stunkard AJ. A multicenter evaluation of a proprietary weight reduction program for the treatment of marked obesity. Arch Intern Med. 1992. 152:961–966.

7. Flechtner-Mors M, Ditschuneit HH, Johnson TD, Suchard MA, Adler G. Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results. Obes Res. 2000. 8:399–402.

8. James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet. 2000. 356:2119–2125.

9. Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999. 281:235–242.

10. Whatley JE, Gillespie WJ, Honig J, Walsh MJ, Blackburn AL, Blackburn GL. Does the amount of endurance exercise in combination with weight training and a very-low-energy diet affect resting metabolic rate and body composition? Am J Clin Nutr. 1994. 59:1088–1092.

11. Pasman WJ, Saris WH, Westerterp-Plantenga MS. Predictors of weight maintenance. Obes Res. 1999. 7:43–50.

12. Binks M, O'Neil MP. Referral sources to a weight management program: relation to outcome. J Gen Intern Med. 2002. 17:596–603.

13. Grodstein F, Levine R, Troy L, Spencer T, Colditz GA, Stampfer MJ. Three-year follow-up of participants in a commercial weight loss program. Can you keep it off? Arch Intern Med. 1996. 156:1302–1306.

14. Ballor DL, Keesey RE. A meta-analysis of the factors affecting exercise-induced changes in body mass, fat mass and fat-free mass in males and females. Int J Obes. 1991. 15:717–726.

15. Foster GD, Wadden TA, Vogt RA, Brewer G. What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol. 1997. 65:79–85.

16. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003. 289:1799–1804.

17. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999. 282:2131–2135.

18. Oh HS, Seo WS. The Compound Relationship of Smoking and Alcohol Consumption with Obesity. Yonsei Med J. 2001. 42:480–487.

19. Moon YI, Park HR, Koo HY, Kim HS. Effects of behavior modification on body image, depression and body fat in obese Korean elementary school children. Yonsei Med J. 2004. 29. 45:61–67.